LINC-PINT and nonpapillary renal cell carcinoma: Mortality and expression levels of LINC-PINT and AC008870.2 increased with increasing risk score, while AC108449.2, AC009120.2 and AC007637.1 decreased in patients with ccRCC (Figure 2B, 2C).